Micaela Dawson

Digesting Digital Medicine: Healthcare Benefits When Smart Pills Track When Taken

/0 Comments/in , /by Micaela Dawson
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Host Joe Selvaggi and Pioneer Institute’s Bill Smith talk with Valerie Sullivan, President and CEO of EtectRX about the health care costs of improperly taking prescriptions and the promise of smart pills to signal and track medicines when ingested.

Guest:

Valerie Sullivan is President and CEO of etectRX where she is passionate about creating meaningful, cost-effective solutions across the healthcare ecosystem by leveraging patient engagement and digital technology to support greater outcomes, more therapeutic impact and the?potential to serve an unmet need. Prior to joining etectRx, she served as President of InVentiv Patient Access Solutions (sold to Xerox in 2015), a tech-enabled patient support services company. In addition, she served as Vice President and General Manager of the Patient Service Center at Pear Therapeutics, a program that she envisioned and built from the ground up. She began her career in healthcare working at Pfizer for over 15 years. Ms. Sullivan serves as an independent member on the board of directors at CareMetx and Two Labs Pharma Services. As well, she is Chairman at the Group Insurance Commission, a quasi-state agency in the Commonwealth of MA. She is on faculty at Bentley University as adjunct professor in the Management Department. Ms. Sullivan holds a Bachelor of Arts in Chemistry and Economics from College of the Holy Cross in Worcester, Massachusetts, and an MBA in Finance and Marketing from Northeastern University.

Get new episodes of Hubwonk in your inbox!

Recent episodes:

Federal Firearm Forfeiture: SCOTUS Considers Gun Rights and Due Process

Joe Selvaggi hosts a conversation with constitutional legal expert Clark Neily, who delves into the facts and legal complexities surrounding USA v. Rahimi, currently before the Supreme Court. This case questions the forfeiture of Second Amendment rights for individuals accused of domestic abuse.

Diversity’s Dubious Definition: Harvard Case Spells End to Racial Classifications

Joe Selvaggi discusses the implications of the Students for Fair Admissions v. Harvard case for race and ethnicity-based programs with David Bernstein, a Distinguished Law Professor at George Mason University and an Adjunct Fellow at the CATO Institute.

Untangling Unsheltered Encampments: Home Is Where the Help Lies

Joe Selvaggi discusses the challenges posed by homeless encampments, like Boston's Mass and Cass, with Dr. Judge Glock, the director of research at the Manhattan Institute. They also explore policy alternatives aimed at addressing the needs of both the community and the unsheltered individuals.

Ruining Research Rewards: Price Controls Come for University Patents and Products

Joe Selvaggi talks with Pioneer Institute Senior Fellow Dr. Bill Smith about the benefit of the Bayh-Dole Act’s protection of intellectual property rights for university research patents and the risk posed to the nation and the local economy from recent efforts to consider price controls on products developed from patented discoveries.

Farmers Welfare Bill: Rethinking Costly and Environmentally Distortive Subsidies

Joe Selvaggi discusses the cost and consequences of the $1.5 trillion decade-long subsidies in the farm bill with Chris Edwards, Chair of Fiscal Studies at the Cato Institute. These subsidies have the potential to negatively impact incentives for consumers, producers, and those concerned about the environment.

Predatory Tax Ruling: Supreme Court Closes Door on Home Equity Theft

Joe Selvaggi talks with Pacific Legal Foundation’s state legal policy deputy, attorney Jim Manley, about home equity theft, a practice that has taken 350 properties in Massachusetts, dispossessing homeowners of more than $50 million in equity.

Sweden’s Pandemic Paradigm: Does Trust in Citizenry Save Lives

Joe Selvaggi talks with Johan Norberg, author and senior fellow at CATO Institute, about his analysis of Sweden’s resistance to government-mandated COVID-19 control measures, as well as Sweden’s public health outcomes relative to the U.S and peer nations.

Breast Cancer Risk: Testing to Tailored Screening, Treatment, and Prevention

Joe Selvaggi talks with precision medicine expert, Alva 10 CEO Hannah Mamuszka about how individualized testing can both detect and substantially reduce the incidence of breast cancer, a disease that accounts for more than 40k deaths each year.

Landlord’s Foreseeable Duty: Who Is Liable When Crime Lands on the Doorstep?

Joe Selvaggi talks with retired Federal Judge Frank Bailey, president of Pioneer Public Interest Law Center, about the Massachusetts Supreme Judicial Court's decision in Hill-Junious v. UTP Realty, LLC, regarding the limits of liability for a landlord when a murder occurs near her tenant’s location, and the challenges facing small entrepreneurs in high-crime communities.

Trump’s Trial’s Tribulations: Legal Merits of Four Federal Felony Fraud Indictments

Joe Selvaggi talks with legal scholar and George Mason University professor Ilya Somin about the legal merits of the federal indictments against former President Donald Trump and what is likely to come next in the legal proceedings against him and other defendants in the cases involving the aftermath of the 2020 presidential election.

Black Box Budget: Late, Loaded, and Lacking Transparency

Joe Selvaggi talks with Pioneer Institute’s Senior Fellow in Economic Opportunity Eileen McAnneny about the features and flaws of the recently passed 2024 Massachusetts state budget now waiting for Governor Healey’s approval.

Sabotaging Strategic Success: How Price Controls Could Imperil U.S. Pharma Industry

Joe Selvaggi talks with Pioneer Institute’s Director of Life Sciences Initiative Dr. Bill Smith about the policies that drove biopharmaceutical company from Europe to the U.S., and how proposed, similar price controls in President Biden’s Fair Prices Act could distort incentives away from innovation and threaten the success of a thriving and vital U.S. industry.